|
FLJ36031 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.345800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.840000E-02 |
| Normal-vs-Stage2 |
1.482630E-01 |
| Normal-vs-Stage3 |
1.428580E-01 |
| Normal-vs-Stage4 |
1.650440E-02 |
| Stage1-vs-Stage2 |
8.409600E-01 |
| Stage1-vs-Stage3 |
8.301800E-01 |
| Stage1-vs-Stage4 |
2.546000E-01 |
| Stage2-vs-Stage3 |
9.892200E-01 |
| Stage2-vs-Stage4 |
3.523600E-01 |
| Stage3-vs-Stage4 |
2.702400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.375600E-02 |
| Normal-vs-AfricanAmerican |
2.033400E-01 |
| Normal-vs-Asian |
3.743200E-01 |
| Caucasian-vs-AfricanAmerican |
6.203800E-01 |
| Caucasian-vs-Asian |
9.930600E-01 |
| AfricanAmerican-vs-Asian |
8.778600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.322300E-02 |
| Normal-vs-Female |
4.327200E-01 |
| Male-vs-Female |
6.365800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.193900E-02 |
| Normal-vs-Extreme_Weight |
6.126200E-02 |
| Normal-vs-Obese |
8.405700E-02 |
| Normal-vs-Extreme_Obese |
4.636000E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.291600E-01 |
| Normal_Weight-vs-Obese |
2.464600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.006200E-01 |
| Extreme_Weight-vs-Obese |
7.956000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.284400E-02 |
| Obese-vs-Extreme_Obese |
3.171900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.209000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.417600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.462140E-02 |
| Normal-vs-Age(81-100Yrs) |
1.217970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.804400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.109900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.654400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.748600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.989400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.251000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.713900E-02 |
| Normal-VS-Type2 PRCC |
4.936900E-03 |
| Normal-VS-KIRP CIMP |
9.883800E-01 |
| Normal-VS-Unclassified PRCC |
1.253830E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.481660E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.757000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.745000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.570240E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.438200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.973800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.578300E-03 |
| Normal-vs-N1 |
3.226800E-01 |
| Normal-vs-N2 |
1.629620E-02 |
| N0-vs-N1 |
1.454240E-01 |
| N0-vs-N2 |
9.305000E-01 |
| N1-vs-N2 |
4.917000E-01 |
|
|
